JP2019507797A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2019507797A5 JP2019507797A5 JP2018548079A JP2018548079A JP2019507797A5 JP 2019507797 A5 JP2019507797 A5 JP 2019507797A5 JP 2018548079 A JP2018548079 A JP 2018548079A JP 2018548079 A JP2018548079 A JP 2018548079A JP 2019507797 A5 JP2019507797 A5 JP 2019507797A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- synthetic nanocarrier
- administered
- uricase
- immunosuppressant
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2022011177A JP7547402B2 (ja) | 2016-03-11 | 2022-01-27 | ペグ化ウリカーゼの処方物および用量 |
| JP2024065367A JP2024102099A (ja) | 2016-03-11 | 2024-04-15 | ペグ化ウリカーゼの処方物および用量 |
Applications Claiming Priority (17)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662307412P | 2016-03-11 | 2016-03-11 | |
| US62/307,412 | 2016-03-11 | ||
| US201662339944P | 2016-05-22 | 2016-05-22 | |
| US62/339,944 | 2016-05-22 | ||
| US201662346348P | 2016-06-06 | 2016-06-06 | |
| US62/346,348 | 2016-06-06 | ||
| US201662397832P | 2016-09-21 | 2016-09-21 | |
| US62/397,832 | 2016-09-21 | ||
| US201662398422P | 2016-09-22 | 2016-09-22 | |
| US62/398,422 | 2016-09-22 | ||
| US201662403664P | 2016-10-03 | 2016-10-03 | |
| US62/403,664 | 2016-10-03 | ||
| US201662430547P | 2016-12-06 | 2016-12-06 | |
| US62/430,547 | 2016-12-06 | ||
| US201762442948P | 2017-01-05 | 2017-01-05 | |
| US62/442,948 | 2017-01-05 | ||
| PCT/US2017/021991 WO2017156513A1 (en) | 2016-03-11 | 2017-03-11 | Formulations and doses of pegylated uricase |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022011177A Division JP7547402B2 (ja) | 2016-03-11 | 2022-01-27 | ペグ化ウリカーゼの処方物および用量 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2019507797A JP2019507797A (ja) | 2019-03-22 |
| JP2019507797A5 true JP2019507797A5 (OSRAM) | 2020-04-16 |
| JP7417354B2 JP7417354B2 (ja) | 2024-01-18 |
Family
ID=58464628
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018548079A Active JP7417354B2 (ja) | 2016-03-11 | 2017-03-11 | ペグ化ウリカーゼの処方物および用量 |
| JP2022011177A Active JP7547402B2 (ja) | 2016-03-11 | 2022-01-27 | ペグ化ウリカーゼの処方物および用量 |
| JP2024065367A Pending JP2024102099A (ja) | 2016-03-11 | 2024-04-15 | ペグ化ウリカーゼの処方物および用量 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022011177A Active JP7547402B2 (ja) | 2016-03-11 | 2022-01-27 | ペグ化ウリカーゼの処方物および用量 |
| JP2024065367A Pending JP2024102099A (ja) | 2016-03-11 | 2024-04-15 | ペグ化ウリカーゼの処方物および用量 |
Country Status (21)
| Country | Link |
|---|---|
| US (3) | US20170258927A1 (OSRAM) |
| EP (2) | EP4445955A3 (OSRAM) |
| JP (3) | JP7417354B2 (OSRAM) |
| KR (2) | KR20180120753A (OSRAM) |
| CN (1) | CN109152819A (OSRAM) |
| AU (2) | AU2017230891B2 (OSRAM) |
| BR (1) | BR112018068249A2 (OSRAM) |
| CA (1) | CA3017365A1 (OSRAM) |
| DK (1) | DK3426285T3 (OSRAM) |
| ES (1) | ES2986077T3 (OSRAM) |
| FI (1) | FI3426285T3 (OSRAM) |
| HR (1) | HRP20241127T1 (OSRAM) |
| HU (1) | HUE068144T2 (OSRAM) |
| IL (2) | IL318183A (OSRAM) |
| LT (1) | LT3426285T (OSRAM) |
| MX (1) | MX2018011012A (OSRAM) |
| PL (1) | PL3426285T3 (OSRAM) |
| PT (1) | PT3426285T (OSRAM) |
| RS (1) | RS65941B1 (OSRAM) |
| SI (1) | SI3426285T1 (OSRAM) |
| WO (1) | WO2017156513A1 (OSRAM) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1871874B1 (en) | 2005-04-11 | 2015-04-08 | Crealta Pharmaceuticals LLC | Variant forms of urate oxidase and use thereof |
| RU2535038C2 (ru) | 2009-06-25 | 2014-12-10 | Криэлта Фармасьютикалз ЭлЭлСи | Способы и наборы для прогнозирования риска инфузионных реакций и опосредованной антителами потери ответа при терапии пэгилированной уриказой с помощью мониторинга содержания мочевой кислоты в сыворотке крови |
| WO2012061717A1 (en) | 2010-11-05 | 2012-05-10 | Selecta Biosciences, Inc. | Modified nicotinic compounds and related methods |
| MX373641B (es) | 2011-04-29 | 2020-05-04 | Selecta Biosciences Inc | Nanoportadores sintéticos tolerogénicos para la terapia contra alergias. |
| CA2843274A1 (en) | 2011-07-29 | 2013-02-07 | Selecta Biosciences, Inc. | Synthetic nanocarriers that generate humoral and cytotoxic t lymphocyte (ctl) immune responses |
| CN105283175A (zh) | 2013-05-03 | 2016-01-27 | 西莱克塔生物科技公司 | 用于降低的或增强的药效学作用的致耐受性合成纳米载体和治疗性大分子 |
| KR20170045344A (ko) | 2014-09-07 | 2017-04-26 | 셀렉타 바이오사이언시즈, 인크. | 항-바이러스 전달 벡터 면역 반응을 약화시키기 위한 방법 및 조성물 |
| CN110234340A (zh) | 2016-11-11 | 2019-09-13 | 好利恩风湿病制药有限责任公司 | 泼尼松和尿酸酶分子的组合疗法及其用途 |
| JP7523909B2 (ja) | 2017-03-11 | 2024-07-29 | セレクタ バイオサイエンシーズ インコーポレーテッド | 抗炎症剤および免疫抑制剤を含む合成ナノキャリアによる組み合わせ処置に関連する方法および組成物 |
| US20200308534A1 (en) | 2017-07-07 | 2020-10-01 | Allena Pharmaceuticals, Inc. | Recombinant uricase enzyme |
| CN109875988B (zh) * | 2018-09-13 | 2021-08-27 | 江西中医药大学 | 一种化合物dhnb缩氨基脲的合成及其在防治痛风与高尿酸血症的应用 |
| WO2020160325A1 (en) | 2019-01-30 | 2020-08-06 | Horizon Pharma Rheumatology Llc | Reducing immunogenicity to pegloticase |
| WO2020160322A1 (en) | 2019-01-30 | 2020-08-06 | Horizon Pharma Rheumatology Llc | Tolerization reduces intolerance to pegloticase and prolongs the urate lowering effect (triple) |
| JP7729783B2 (ja) * | 2019-06-04 | 2025-08-26 | セレクタ バイオサイエンシーズ インコーポレーテッド | ペグ化ウリカーゼの処方物および用量 |
| KR102260478B1 (ko) * | 2019-08-19 | 2021-06-02 | 연세대학교 산학협력단 | 일나트륨 요소화물 결정 용해용 조성물 |
| EP4021482A4 (en) * | 2019-08-30 | 2023-04-19 | Horizon Therapeutics Ireland Dac | PEGLOTICASE FOR THE TREATMENT OF GOUT IN KIDNEY TRANSPLANT RECIPIENT |
| CN115038441A (zh) * | 2019-10-21 | 2022-09-09 | 西莱克塔生物科技公司 | 用于治疗肝疾病和病症的方法和组合物 |
| MX2022005506A (es) * | 2019-11-08 | 2022-08-10 | Selecta Biosciences Inc | Formulaciones y dosis de uricasa pegilada. |
| KR102200329B1 (ko) * | 2019-11-11 | 2021-01-08 | 광주과학기술원 | 반감기 증가를 위한 치료용 단백질-지방산 접합체 및 이의 용도 |
| AU2021324665A1 (en) * | 2020-08-10 | 2023-04-13 | Horizon Therapeutics Usa, Inc. | Methods of treating gout |
| US12269875B2 (en) | 2023-08-03 | 2025-04-08 | Jeff R. Peterson | Gout flare prevention methods using IL-1BETA blockers |
| WO2025076412A1 (en) * | 2023-10-04 | 2025-04-10 | Gro Biosciences Inc. | Modified polypeptides and methods of making and uses thereof |
Family Cites Families (36)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4946929A (en) | 1983-03-22 | 1990-08-07 | Massachusetts Institute Of Technology | Bioerodible articles useful as implants and prostheses having predictable degradation rates |
| US4638045A (en) | 1985-02-19 | 1987-01-20 | Massachusetts Institute Of Technology | Non-peptide polyamino acid bioerodible polymers |
| US4806621A (en) | 1986-01-21 | 1989-02-21 | Massachusetts Institute Of Technology | Biocompatible, bioerodible, hydrophobic, implantable polyimino carbonate article |
| CA1340581C (en) | 1986-11-20 | 1999-06-08 | Joseph P. Vacanti | Chimeric neomorphogenesis of organs by controlled cellular implantation using artificial matrices |
| US5736372A (en) | 1986-11-20 | 1998-04-07 | Massachusetts Institute Of Technology | Biodegradable synthetic polymeric fibrous matrix containing chondrocyte for in vivo production of a cartilaginous structure |
| US5759830A (en) | 1986-11-20 | 1998-06-02 | Massachusetts Institute Of Technology | Three-dimensional fibrous scaffold containing attached cells for producing vascularized tissue in vivo |
| US5019379A (en) | 1987-07-31 | 1991-05-28 | Massachusetts Institute Of Technology | Unsaturated polyanhydrides |
| US5010167A (en) | 1989-03-31 | 1991-04-23 | Massachusetts Institute Of Technology | Poly(amide-and imide-co-anhydride) for biological application |
| US5399665A (en) | 1992-11-05 | 1995-03-21 | Massachusetts Institute Of Technology | Biodegradable polymers for cell transplantation |
| US5512600A (en) | 1993-01-15 | 1996-04-30 | Massachusetts Institute Of Technology | Preparation of bonded fiber structures for cell implantation |
| US5514378A (en) | 1993-02-01 | 1996-05-07 | Massachusetts Institute Of Technology | Biocompatible polymer membranes and methods of preparation of three dimensional membrane structures |
| US5565215A (en) | 1993-07-23 | 1996-10-15 | Massachusettes Institute Of Technology | Biodegradable injectable particles for imaging |
| US5543158A (en) | 1993-07-23 | 1996-08-06 | Massachusetts Institute Of Technology | Biodegradable injectable nanoparticles |
| US6007845A (en) | 1994-07-22 | 1999-12-28 | Massachusetts Institute Of Technology | Nanoparticles and microparticles of non-linear hydrophilic-hydrophobic multiblock copolymers |
| US5716404A (en) | 1994-12-16 | 1998-02-10 | Massachusetts Institute Of Technology | Breast tissue engineering |
| US6123727A (en) | 1995-05-01 | 2000-09-26 | Massachusetts Institute Of Technology | Tissue engineered tendons and ligaments |
| JP3462313B2 (ja) | 1995-08-24 | 2003-11-05 | キッコーマン株式会社 | 変異型ウリカーゼ、変異型ウリカーゼ遺伝子、新規な組み換え体ｄｎａ及び変異型ウリカーゼの製造法 |
| US6095148A (en) | 1995-11-03 | 2000-08-01 | Children's Medical Center Corporation | Neuronal stimulation using electrically conducting polymers |
| US5902599A (en) | 1996-02-20 | 1999-05-11 | Massachusetts Institute Of Technology | Biodegradable polymer networks for use in orthopedic and dental applications |
| AU735648B2 (en) | 1996-07-12 | 2001-07-12 | Ariad Pharmaceuticals, Inc. | Materials and method for treating or preventing pathogenic fungal infection |
| US5837752A (en) | 1997-07-17 | 1998-11-17 | Massachusetts Institute Of Technology | Semi-interpenetrating polymer networks |
| US6506577B1 (en) | 1998-03-19 | 2003-01-14 | The Regents Of The University Of California | Synthesis and crosslinking of catechol containing copolypeptides |
| US6686446B2 (en) | 1998-03-19 | 2004-02-03 | The Regents Of The University Of California | Methods and compositions for controlled polypeptide synthesis |
| US6632922B1 (en) | 1998-03-19 | 2003-10-14 | The Regents Of The University Of California | Methods and compositions for controlled polypeptide synthesis |
| US6632671B2 (en) | 2000-02-28 | 2003-10-14 | Genesegues, Inc. | Nanoparticle encapsulation system and method |
| GB0025414D0 (en) | 2000-10-16 | 2000-11-29 | Consejo Superior Investigacion | Nanoparticles |
| US6913915B2 (en) | 2001-08-02 | 2005-07-05 | Phoenix Pharmacologics, Inc. | PEG-modified uricase |
| US6818732B2 (en) | 2001-08-30 | 2004-11-16 | The Regents Of The University Of California | Transition metal initiators for controlled poly (beta-peptide) synthesis from beta-lactam monomers |
| CA2549341C (en) | 2003-12-19 | 2014-06-10 | The University Of North Carolina At Chapel Hill | Methods for fabricating isolated micro- and nano- structures using soft or imprint lithography |
| WO2006080951A2 (en) | 2004-07-01 | 2006-08-03 | Yale University | Targeted and high density drug loaded polymeric materials |
| CA2917512C (en) | 2007-10-12 | 2025-08-05 | President And Fellows Of Harvard College | VACCINE NANOTECHNOLOGY |
| CN101676291B (zh) | 2008-09-18 | 2012-05-09 | 上海海和药物研究开发有限公司 | 一类雷帕霉素碳酸酯类似物、其药物组合物及其制备方法和用途 |
| MX373641B (es) * | 2011-04-29 | 2020-05-04 | Selecta Biosciences Inc | Nanoportadores sintéticos tolerogénicos para la terapia contra alergias. |
| CN105283175A (zh) * | 2013-05-03 | 2016-01-27 | 西莱克塔生物科技公司 | 用于降低的或增强的药效学作用的致耐受性合成纳米载体和治疗性大分子 |
| WO2014179771A1 (en) * | 2013-05-03 | 2014-11-06 | Selecta Biosciences, Inc. | Dosing combinations for reducing undesired humoral immune responses |
| IL283699B (en) | 2014-11-05 | 2022-09-01 | Selecta Biosciences Inc | Methods and preparations related to artificial nanocarriers with rapamycin in a super-saturated steady state |
-
2017
- 2017-03-11 AU AU2017230891A patent/AU2017230891B2/en active Active
- 2017-03-11 CA CA3017365A patent/CA3017365A1/en active Pending
- 2017-03-11 EP EP24177803.4A patent/EP4445955A3/en active Pending
- 2017-03-11 SI SI201731543T patent/SI3426285T1/sl unknown
- 2017-03-11 WO PCT/US2017/021991 patent/WO2017156513A1/en not_active Ceased
- 2017-03-11 KR KR1020187029146A patent/KR20180120753A/ko not_active Ceased
- 2017-03-11 KR KR1020227029367A patent/KR20220123332A/ko active Pending
- 2017-03-11 MX MX2018011012A patent/MX2018011012A/es unknown
- 2017-03-11 JP JP2018548079A patent/JP7417354B2/ja active Active
- 2017-03-11 CN CN201780028609.1A patent/CN109152819A/zh active Pending
- 2017-03-11 PT PT177152980T patent/PT3426285T/pt unknown
- 2017-03-11 DK DK17715298.0T patent/DK3426285T3/da active
- 2017-03-11 US US15/456,520 patent/US20170258927A1/en not_active Abandoned
- 2017-03-11 RS RS20240946A patent/RS65941B1/sr unknown
- 2017-03-11 HR HRP20241127TT patent/HRP20241127T1/hr unknown
- 2017-03-11 BR BR112018068249-7A patent/BR112018068249A2/pt unknown
- 2017-03-11 FI FIEP17715298.0T patent/FI3426285T3/fi active
- 2017-03-11 HU HUE17715298A patent/HUE068144T2/hu unknown
- 2017-03-11 IL IL318183A patent/IL318183A/en unknown
- 2017-03-11 LT LTEPPCT/US2017/021991T patent/LT3426285T/lt unknown
- 2017-03-11 PL PL17715298.0T patent/PL3426285T3/pl unknown
- 2017-03-11 EP EP17715298.0A patent/EP3426285B1/en active Active
- 2017-03-11 ES ES17715298T patent/ES2986077T3/es active Active
-
2018
- 2018-09-12 IL IL261700A patent/IL261700A/en unknown
-
2022
- 2022-01-27 JP JP2022011177A patent/JP7547402B2/ja active Active
-
2024
- 2024-04-15 JP JP2024065367A patent/JP2024102099A/ja active Pending
- 2024-07-15 AU AU2024204851A patent/AU2024204851A1/en not_active Abandoned
- 2024-08-29 US US18/818,714 patent/US20250090451A1/en active Pending
- 2024-10-31 US US18/933,195 patent/US20250057756A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2019507797A5 (OSRAM) | ||
| JP2024102099A5 (OSRAM) | ||
| JP2022068180A5 (OSRAM) | ||
| FI3426285T3 (fi) | Pegyloidun urikaasin formulaatioita ja annoksia | |
| JP2020510687A5 (OSRAM) | ||
| US11648206B2 (en) | Sustained-release formulations of colchicine and methods of using same | |
| Fattore et al. | Novel medications for epilepsy | |
| CN102869349A (zh) | 耐酒精的肠溶药物组合物 | |
| JP2018520189A5 (OSRAM) | ||
| KR20210147083A (ko) | 다발경화증 치료용 조합 요법 | |
| CN102781240A (zh) | 用拉喹莫德和甲氨蝶呤的组合治疗类风湿性关节炎 | |
| JP2009215293A5 (OSRAM) | ||
| JP2019501881A5 (OSRAM) | ||
| BR112020008128A2 (pt) | comprimidos de liberação retardada de deferiprona e métodos para utilização dos mesmos | |
| EP3079704B1 (en) | A pharmaceutical composition containing combinations of nicotinamide and 5-aminosalicylic acid for beneficially influencing the intestinal microbiota and/or treating gastrointestinal inflammation | |
| CN118384281A (zh) | 聚乙二醇化尿酸酶的制剂和剂量 | |
| JP2016512247A5 (OSRAM) | ||
| JP2015518002A5 (OSRAM) | ||
| Jurgens et al. | The use of conventional disease-modifying anti-rheumatic drugs in established RA | |
| JPWO2020247625A5 (OSRAM) | ||
| US20180368458A1 (en) | Time release vitamins and minerals in edible oils | |
| Cristancho et al. | The role of quetiapine extended release in the treatment of bipolar depression | |
| JP2016504390A5 (OSRAM) | ||
| JP6697539B2 (ja) | コルヒチンの徐放性製剤およびその使用方法 | |
| JPWO2021092354A5 (OSRAM) |